ANNOUNCING! Sept 8-10, 2025
Venue TBA

2024 Advisory Committee

Zhengming Chen, Ph.D.
Senior Director, Pharmaceutical Science
Shionogi, Inc.
 
Roger Hanselmann, Ph.D.
Director of Process Research & Development
Akebia Therapeutics, Inc.
 
William Leong
Senior Director, CMC
Newron Pharmaceuticals
 
Chuk Man
Senior Scientist, Medicinal Chemistry
Boehringer-Ingelheim Pharmaceuticals
 
Robert Mills, Ph.D.
VP, CMC
Intrexon Corporation
 
Deborah Minor, Ph.D.
President
Drug Discovery Alliances, Inc.
 
Tom Niemeyer
Head, Chemical R&D Global External Supply
Pfizer
 
Max Reeve, Ph.D.
Director, Drug Substance Development
Melinta Therapeutics
 
Surendra Singh, Ph.D.
Director Drug Substance
Verastem, Inc.
 
Richland Tester, Ph.D.
Senior Manager Medicinal Chemistry
Celgene Avilomics Research
 
James Tornos, Ph.D.
Director, PharmaTX Research Scientific Services
Pfizer
 
Ephraim Vidal, Ph.D.
Associate Director, Development and Manufacturing
Receptos, a Celgene company
 
Winston Wu, Ph.D.
VP, Chemical Development
Lexicon Pharmaceuticals
 
Scott Zook
Director CMC
Neurocrine Biosciences